Source:http://linkedlifedata.com/resource/pubmed/id/15466216
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19
|
pubmed:dateCreated |
2004-10-6
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7178-80
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15466216-Androgens,
pubmed-meshheading:15466216-Clinical Trials as Topic,
pubmed-meshheading:15466216-Humans,
pubmed-meshheading:15466216-Male,
pubmed-meshheading:15466216-Neoplasms, Hormone-Dependent,
pubmed-meshheading:15466216-Prostatic Neoplasms,
pubmed-meshheading:15466216-Receptors, Androgen
|
pubmed:year |
2004
|
pubmed:articleTitle |
Symposium on androgen action in prostate cancer.
|
pubmed:affiliation |
Mayo Clinic, Rochester, Minnesota 55905, USA. tindall.don@mayo.edu
|
pubmed:publicationType |
Congresses
|